Testabol Enanthate 250 mg is an oil-based testosterone enanthate injectable manufactured by British Dragon and dosed at 250 mg/mL in a 10 mL vial.
Testabol Enanthate 250 mg is an injectable anabolic-androgenic steroid containing testosterone enanthate, a long-acting testosterone ester. Testosterone enanthate has a half-life of approximately seven to nine days when injected intramuscularly. Its extended release profile makes it suitable for both medically supervised testosterone replacement therapy and non-medical bodybuilding use.
In clinical practice, testosterone enanthate is FDA-approved for testosterone replacement therapy in men with primary hypogonadism or hypogonadotropic hypogonadism. It is also approved for delayed puberty in boys and metastatic breast cancer in women. The Endocrine Society recommends testosterone therapy targeting the mid-normal range of approximately 400 to 700 ng/dL. In bodybuilding and performance-enhancement settings, long-acting testosterone such as Testabol Enanthate 250 mg is commonly referenced as a foundation compound in mass-building cycles because of its anabolic and androgenic activity.
Testosterone supports processes involved in muscle protein synthesis, recovery, strength, sexual function and maintenance of normal male physiological characteristics. When testosterone is used at supraphysiologic levels for physique or performance enhancement, however, the potential for adverse effects increases and such use falls outside approved medical indications.
Testabol Enanthate 250 mg uses MCT oil as its carrier oil, providing the oil base for the testosterone enanthate formulation.
Testosterone enanthate is a long-acting testosterone ester designed for gradual release after administration. Its extended release characteristics distinguish it from faster-acting testosterone preparations and make it one of the most established injectable forms of testosterone.
The enanthate ester slows the release of testosterone from the injection site, producing a longer duration of activity than short-acting preparations such as testosterone propionate or unesterified testosterone suspension. The half-life of testosterone enanthate is approximately seven to nine days.
Once the esterified compound is released and metabolized, the active hormone is testosterone. The ester primarily influences the rate of release and duration of activity rather than changing the underlying anabolic and androgenic properties of testosterone itself.
These characteristics explain why testosterone enanthate is encountered both in medically supervised testosterone replacement therapy and in non-medical bodybuilding settings where a longer-acting testosterone preparation is commonly preferred. Medical guidelines typically recommend administration every two to four weeks for replacement therapy.
Testosterone enanthate releases more gradually than short-acting esters such as testosterone propionate. Its release characteristics are broadly comparable to testosterone cypionate, with a reported half-life of seven to nine days compared to approximately eight days for cypionate.
British Dragon offers several testosterone formulations built around different esters, concentrations and release profiles. The main practical distinction between these preparations is how quickly testosterone is released and how long the formulation remains active after administration.
Enanthate and cypionate are both long-acting testosterone esters with broadly similar release characteristics. The Testabol Depot provides a closely related long-acting cypionate alternative, while Testabol Propionate uses a shorter-acting ester. British Dragon also offers Sustabol 350, a multi-ester testosterone formulation combining several release profiles.
Published laboratory reports for Testabol Enanthate 250 mg are shown below with the test date, measured concentration and percentage of the product's 250 mg/mL label claim.
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
The information below is provided for educational reference only. Testosterone enanthate is a prescription androgen; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
In medically supervised testosterone replacement therapy, testosterone enanthate dosing is individualized based on laboratory results, symptom response and the specific product used. Medical guidelines typically reference 50 to 400 mg every two to four weeks for hypogonadal males. The Endocrine Society recommends targeting a mid-normal serum testosterone range of approximately 400 to 700 ng/dL. In non-medical bodybuilding settings, long-acting testosterone such as Testabol Enanthate 250 mg is commonly referenced in the range of 250–500 mg per week, though such use falls outside approved medical indications.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| TRT (medical) | 50–400 mg / 2–4 weeks | Every 2–4 weeks |
| Bodybuilding (non-medical, beginner) | 250–350 mg / week | Once or twice weekly |
| Bodybuilding (non-medical, experienced) | 350–500 mg / week | Twice weekly or split |
In non-medical bodybuilding contexts, long-acting testosterone is frequently used as a base compound in bulking or mass-building cycles and may be combined with other injectable or oral compounds. British Dragon offers several products that are commonly referenced in this context, including Decabol 250 and Methanabol for bulking, or Stanabol 10 during cutting phases where maintaining muscle while reducing fat is a goal.
As with any long-acting testosterone, cycle structure, duration and support compounds should be considered in the context of individual experience, health status and bloodwork where possible.
Testosterone enanthate aromatizes, meaning some of it converts to estrogen. This can contribute to water retention, gynecomastia and elevated blood pressure in susceptible individuals. Aromatase inhibitors such as Anastrozole are commonly referenced in this context, though use should be based on individual response and bloodwork where possible.
Testosterone enanthate is not liver toxic in the way oral C17-alpha-alkylated steroids are, but cholesterol and hematocrit levels should be monitored during use. Injectable testosterone preparations are associated with a higher incidence of elevated hematocrit compared to gels or patches.
After completing a cycle with Testabol Enanthate 250 mg, post-cycle therapy is commonly recommended to help restore endogenous testosterone production and support hormonal recovery. Agents such as Clomiphene and Tamoxifen are commonly referenced for this purpose.
PCT protocols vary based on cycle length, compounds used and individual factors. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Testosterone enanthate is a prescription androgen that can affect hormonal, reproductive, cardiovascular and hematologic function. Medical testosterone therapy requires appropriate diagnosis, clinical supervision and ongoing monitoring.
Testosterone replacement therapy is intended for appropriately diagnosed testosterone deficiency. Clinical evaluation normally considers both compatible symptoms and consistently low testosterone concentrations rather than symptoms alone.
Use of testosterone at supraphysiologic levels for bodybuilding or performance enhancement falls outside approved replacement therapy and can increase exposure to androgen-related adverse effects.
Higher-than-physiologic testosterone exposure can carry additional health risks. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Testosterone therapy can increase red blood cell production and hematocrit. Excessive elevation can require medical evaluation and changes to treatment. Injectable testosterone preparations are associated with a 43.8% incidence of elevated hematocrit compared to 11.3 to 17.9% for gels.
Testosterone can suppress the body's own reproductive hormone signaling and reduce sperm production. Oligospermia may occur at high dosages. Fertility is therefore an important consideration, particularly for men planning to have children.
Other potential androgen-related effects can include acne, changes in skin oil production, fluid retention and changes in prostate-related symptoms. The FDA label lists the following adverse reactions in males: gynecomastia, excessive frequency and duration of penile erections, oligospermia, hirsutism, male pattern baldness, acne, and polycythemia.
Testosterone therapy is not appropriate for everyone. The FDA label states that testosterone enanthate is contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate, and in women who are pregnant.
Existing cardiovascular disease, urinary or prostate symptoms, abnormal blood counts and other medical conditions should be discussed with a qualified healthcare professional before testosterone therapy is considered.
Medically supervised testosterone therapy typically involves follow-up assessment to evaluate treatment response, adverse effects and relevant laboratory markers. Medical guidelines recommend checking hematocrit at baseline and approximately every three months while on therapy. If hematocrit exceeds 54%, testosterone should be discontinued until it decreases to an acceptable level.
Serum testosterone should be measured at trough levels, and prostate health should be monitored in men aged 40 and older.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Testabol Enanthate 250 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Testabol Enanthate 250 mg product, use the security features on the vial label and cross-check them with official British Dragon presentation. Genuine British Dragon vials typically feature specific label characteristics and packaging details that distinguish them from counterfeits.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Testabol Enanthate 250 mg, testosterone enanthate, release characteristics, product strength and laboratory testing.
Testabol Enanthate 250 mg contains testosterone enanthate, a long-acting testosterone ester. In medical practice it is FDA-approved for testosterone replacement therapy in men with primary hypogonadism or hypogonadotropic hypogonadism. In non-medical bodybuilding settings it is commonly referenced as a base compound for muscle growth, strength and recovery, though such use falls outside approved medical indications.
In medically supervised therapy, testosterone enanthate is typically administered every two to four weeks. Because of its long-acting enanthate ester, bodybuilding contexts commonly reference once or twice weekly injection for more stable blood levels. A medical resource notes that 250 mg every four weeks is a typical replacement dose.
Testosterone can suppress endogenous testosterone production. In non-medical bodybuilding contexts, post-cycle therapy is commonly referenced after a cycle to support hormonal recovery. Agents such as Clomiphene and Tamoxifen are commonly discussed for this purpose.
Testosterone enanthate is a long-acting ester of testosterone. After administration, the esterified testosterone is released gradually and ultimately provides active testosterone, which has both androgenic and anabolic effects. Testosterone supports muscle protein synthesis, recovery, strength, sexual function and maintenance of male physiological characteristics.
Testosterone enanthate has a half-life of approximately seven to nine days when injected intramuscularly. Visible effects on physique and performance are typically referenced as taking several weeks to become apparent, depending on dose, diet, training, and individual factors.
There is no single testosterone ester that is universally best. Testosterone enanthate and testosterone cypionate are both long-acting preparations with broadly similar release characteristics and half-lives. The appropriate formulation depends on the circumstances in which testosterone is being used.
Testosterone enanthate and testosterone cypionate are closely related long-acting testosterone esters. Both are designed to slow the release of testosterone after administration and have broadly comparable half-lives (seven to nine days for enanthate versus approximately eight days for cypionate). British Dragon offers Testabol Depot as a comparable cypionate-based formulation.
The principal difference is the ester and resulting release profile. Testosterone enanthate is a longer-acting ester, whereas testosterone propionate is released more rapidly and has a shorter duration of activity. British Dragon's shorter-acting alternative is Testabol Propionate.
A milligram amount cannot be classified as appropriate or excessive without considering the medical indication, individual response, laboratory results, treatment schedule and the specific testosterone product being used. Medical guidelines reference 50 to 400 mg every two to four weeks for replacement therapy. Testosterone treatment should therefore be individualized by a qualified healthcare professional.
Testabol Enanthate 250 mg is labeled at 250 mg of testosterone enanthate per mL. It is supplied in a 10 mL vial, giving 2,500 mg of total labeled testosterone enanthate content per vial.
Yes. A published laboratory report dated March 20, 2026 measured Testabol Enanthate 250 mg at 250.17 mg/mL, equivalent to 100.07% of its 250 mg/mL label claim. The complete report can be viewed in the Lab Reports tab.
Yes. Injectable testosterone preparations are associated with a 43.8% incidence of elevated hematocrit, compared to 11.3 to 17.9% for gels. Medical guidelines recommend checking hematocrit at baseline and approximately every three months while on therapy. If hematocrit exceeds 54%, testosterone should be discontinued until it decreases to an acceptable level.